Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

3.02
-0.0300-0.98%
Pre-market: 3.110.0900+2.98%09:21 EDT
Volume:149.95K
Turnover:450.50K
Market Cap:4.97M
PE:-0.26
High:3.14
Open:2.92
Low:2.86
Close:3.05
Loading ...
Aug 09, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jul 21, 2021

Major Issues Report

8-K - Current report
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 12, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 08, 2021

Major Issues Report

8-K - Current report
Jul 07, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jul 07, 2021

Major Issues Report

8-K - Current report
Jul 06, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jul 01, 2021

Major Issues Report

8-K - Current report
Jul 01, 2021

Major Issues Report

8-K - Current report
Jun 30, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jun 29, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 11, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Jun 08, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 08, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]